Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transcription linked to recombination: a gene-internal promoter coincides with the recombination hot spot II of the human MLL gene

Abstract

The MLL gene is frequently involved in chromosomal translocations associated with high-risk acute leukaemia. Infant and therapy-related acute leukaemia patients display chromosomal breakpoints preferentially clustered in the telomeric portion of the MLL breakpoint cluster region (SCII). Here, we demonstrate that SCII colocalizes with a gene-internal promoter element in the mouse and human MLL gene, respectively. The mRNA generated encodes an N-terminally truncated version of MLL that still exhibits many functional regions, including the C-terminal SET-domain. Etoposide-induced DNA double-strand breaks colocalize with the binding site of RNA polymerase II and the transcription initiation region, but not with a nearby Topo II consensus sequence. Thus, the observed genomic instability of the human MLL gene is presumably linked to transcriptional processes. The consequences of this novel finding for the creation of chromosomal translocations, the biology of the MLL protein and for MLL-mediated acute leukaemia are discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Andersen MK, Christiansen DH, Jensen BA, Ernst P, Hauge G, Pedersen-Bjergaard J . (2001). Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Brit J Haematol 114: 539–543.

    Article  CAS  Google Scholar 

  • Aplan PD, Chervinsky DS, Stanulla M, Burhans WC . (1996). Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87: 2649–2658.

    CAS  PubMed  Google Scholar 

  • Betti CJ, Villalobos MJ, Diaz MO, Vaughan AT . (2001). Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system. Cancer Res 61: 4550–4555.

    CAS  PubMed  Google Scholar 

  • Betti CJ, Villalobos MJ, Jiang Q, Cline E, Diaz MO, Loredo G et al. (2005). Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity. Leukemia 19: 2289–2295.

    Article  CAS  Google Scholar 

  • Blackwell TK, Moore MW, Yancopoulos GD, Suh H, Lutzker S, Selsing E et al. (1986). Recombination between immunoglobulin variable region gene segments is enhanced by transcription. Nature 324: 585–589.

    Article  CAS  Google Scholar 

  • Broeker PL, Super HG, Thirman MJ, Pomykala H, Yonebayashi Y, Tanabe S et al. (1996). Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 87: 1912–1922.

    CAS  PubMed  Google Scholar 

  • Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. (2004). MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101: 2999–3004.

    Article  CAS  Google Scholar 

  • Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK et al. (1998). Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci USA 95: 13176–13181.

    Article  CAS  Google Scholar 

  • Gillert E, Leis T, Repp R, Reichel M, Hösch A, Breitenlohner I et al. (1999). A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene 18: 4663–4671.

    Article  CAS  Google Scholar 

  • Goto H, Shimazaki C, Tatsumi T, Yamagata N, Inaba T, Fujita N et al. (1994). Acute myelomonocytic leukemia after treatment with chronic oral etoposide: are MLL and LTG9 genes targets for etoposide? Int J Hematol 60: 145–149.

    CAS  PubMed  Google Scholar 

  • Hsieh JJ, Cheng EH, Korsmeyer SJ . (2003). Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression. Cell 115: 293–303.

    Article  CAS  Google Scholar 

  • Khobta A, Carlo-Stella C, Capranico G . (2004). Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene. Cancer Res 64: 2656–2662.

    Article  CAS  Google Scholar 

  • Libura J, Slater DJ, Felix CA, Richardson C . (2005). Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion. Blood 105: 2124–2131.

    Article  CAS  Google Scholar 

  • Margueron R, Trojer P, Reinberg D . (2005). The key to development: interpreting the histone code? Curr Opin Genet Dev 15: 163–176.

    Article  CAS  Google Scholar 

  • Mitterbauer-Hohendanner G, Mannhalter C . (2004). The biological and clinical significance of MLL abnormalities in haematological malignancies. Eur J Clin Invest 34: 12–24.

    Article  CAS  Google Scholar 

  • Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, Wassell R et al. (2002). ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 10: 1119–1128.

    Article  CAS  Google Scholar 

  • Nasr F, Macintyre E, Venuat AM, Bayle C, Carde P, Ribrag V . (1997). Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents. Leuk Lymphoma 25: 399–401.

    Article  CAS  Google Scholar 

  • Quandt K, Frech K, Karas H, Wingender E, Werner T . (1995). MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucl Acids Res 23: 4878–4884.

    Article  CAS  Google Scholar 

  • Rabbitts TH . (1994). Chromosomal translocations in human cancer. Nature 372: 143–149.

    Article  CAS  Google Scholar 

  • Reichel M, Gillert E, Angermüller S, Hensel JP, Heidel F, Lode M et al. (2001). Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene 20: 2900–2907.

    Article  CAS  Google Scholar 

  • Reichel M, Gillert E, Nilson I, Siegler G, Greil J, Fey GH et al. (1998). Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation. Oncogene 17: 3035–3044.

    Article  CAS  Google Scholar 

  • Richardson C, Jasin M . (2000). Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405: 697–700.

    Article  CAS  Google Scholar 

  • Sim SP, Liu LF . (2001). Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis. J Biol Chem 276: 31590–31595.

    Article  CAS  Google Scholar 

  • Stanulla M, Wang J, Chervinsky DS, Thandla S, Aplan PD . (1997). DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol Cell Biol 17: 4070–4079.

    Article  CAS  Google Scholar 

  • Strissel PL, Strick R, Rowley JD, Zeleznik-Le NJ . (1998). An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood 92: 3793–3803.

    CAS  PubMed  Google Scholar 

  • Uhl J, Klan N, Rose M, Entian KD, Werz O, Steinhilber D . (2002). The 5-lipoxygenase promoter is regulated by DNA methylation. J Biol Chem 277: 4374–4379.

    Article  CAS  Google Scholar 

  • Yokoyama A, Kitabayashi I, Ayton PM, Cleary ML, Ohki M . (2002). Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood 100: 3710–3718.

    Article  CAS  Google Scholar 

  • Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ . (1995). Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378: 505–508.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Jay Hess for providing the murine MLL wild-type and knockout fibroblast cell lines, and Tatsuya Nakamura and Eli Canaani (Philadelphia, USA) for providing the polyclonal antiserum PAS173. The MAB E3 was a gift from Robert Slany (Erlangen, Germany). We also thank Michael Karas, Martin Stanulla and Malek Djabali for critically reading the manuscript, and Ludger Klein-Hitpass for performing the Affymetrix experiments. This study was supported by research grants N1KR-S12T13 from the BMBF, Ma1876/5-2 and Ma1876/7-1 from the DFG to R.M.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Marschalek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scharf, S., Zech, J., Bursen, A. et al. Transcription linked to recombination: a gene-internal promoter coincides with the recombination hot spot II of the human MLL gene. Oncogene 26, 1361–1371 (2007). https://doi.org/10.1038/sj.onc.1209948

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209948

Keywords

This article is cited by

Search

Quick links